Sambagan, Irene .
HRN: 08-04-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
CO-AMOXICLAV 625MG (TAB)
06/26/2024
07/02/2024
ORAL
625mg
BID
UTI
Waiting Final Action